Fortress Biotech, Inc. (FBIO)
1.93
-0.06
(-3.02%)
USD |
NASDAQ |
Oct 23, 16:00
1.915
-0.02
(-0.78%)
After-Hours: 20:00
Fortress Biotech Market Cap : 64.29M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 64.29M |
| October 22, 2026 | 66.29M |
| October 21, 2026 | 64.62M |
| October 20, 2026 | 64.62M |
| October 19, 2026 | 62.29M |
| October 16, 2026 | 62.29M |
| October 15, 2026 | 63.62M |
| October 14, 2026 | 63.29M |
| October 13, 2026 | 64.96M |
| October 12, 2026 | 70.29M |
| October 09, 2026 | 71.12M |
| October 08, 2026 | 69.62M |
| October 07, 2026 | 67.95M |
| October 06, 2026 | 68.29M |
| October 05, 2026 | 69.62M |
| October 02, 2026 | 67.62M |
| October 01, 2026 | 68.95M |
| September 30, 2026 | 71.29M |
| September 29, 2026 | 73.28M |
| September 28, 2026 | 72.28M |
| September 25, 2026 | 75.95M |
| September 24, 2026 | 75.95M |
| September 23, 2026 | 77.95M |
| September 22, 2026 | 81.61M |
| September 21, 2026 | 80.28M |
| Date | Value |
|---|---|
| September 18, 2026 | 83.61M |
| September 17, 2026 | 83.61M |
| September 16, 2026 | 81.95M |
| September 15, 2026 | 82.94M |
| September 14, 2026 | 84.28M |
| September 11, 2026 | 83.94M |
| September 10, 2026 | 85.61M |
| September 09, 2026 | 87.61M |
| September 08, 2026 | 90.27M |
| September 04, 2026 | 90.61M |
| September 03, 2026 | 90.27M |
| September 02, 2026 | 90.94M |
| September 01, 2026 | 89.27M |
| August 31, 2026 | 91.11M |
| August 28, 2026 | 92.27M |
| August 27, 2026 | 93.27M |
| August 26, 2026 | 93.60M |
| August 25, 2026 | 94.27M |
| August 24, 2026 | 97.60M |
| August 21, 2026 | 95.60M |
| August 20, 2026 | 92.27M |
| August 19, 2026 | 94.94M |
| August 18, 2026 | 96.94M |
| August 17, 2026 | 93.94M |
| August 14, 2026 | 97.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 73.87M |
| Kura Oncology, Inc. | 854.85M |
| Spero Therapeutics, Inc. | 64.54M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
Market Cap Related Metrics
| PE Ratio | 0.7265 |
| PS Ratio | 0.9491 |
| Price to Book Value | 0.3917 |
| Price to Free Cash Flow | 0.5402 |
| Price | 1.93 |
| Earnings Yield | 137.6% |
| Normalized PE Ratio | 0.7882 |